Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

United Therapeutics Corp

NASDAQ: UTHR · Life Sciences · 48 alerts · CIK 1082554

Share price
$587.88Close, Nov 16
Market cap
$25B
Shares outstanding
42.59MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All United Therapeutics Corp filings on SEC EDGAR ↗

4:34 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $587.00 to $597.33 a share (average $593.52) in 11 transactions, worth $5.64M in total on Nov 12, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$5.64M
Shares
9,500
Average price
$593.52
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 12, 2026
4:39 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.64M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $584.20 to $598.63 a share (average $593.99) in 14 transactions, worth $5.64M in total on Nov 11, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$5.64M
Shares
9,500
Average price
$593.99
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 11, 2026
4:38 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.57M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $577.52 to $592.93 a share (average $586.32) in 14 transactions, worth $5.57M in total on Nov 10, 2026. Shares held after the trade: 324,443 (-0.0%).

Value
$5.57M
Shares
9,500
Average price
$586.32
Role
Chairperson & CEO
Holding change
-0.0%
Trade date
Nov 10, 2026
4:36 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $944K of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 1,614 shares of United Therapeutics Corp at $583.80 to $585.63 a share (average $584.59) in 3 transactions, worth $944K in total on Nov 9, 2026. Shares held after the trade: 324,443 (-0.1%).

Value
$944K
Shares
1,614
Average price
$584.59
Role
Chairperson & CEO
Holding change
-0.1%
Trade date
Nov 9, 2026
4:35 PM ET Form 4
Insider Selling

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $4.52M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 7,886 shares of United Therapeutics Corp at $556.52 to $582.79 a share (average $572.69) in 24 transactions, worth $4.52M in total on Nov 9, 2026. Shares held after the trade: 326,057 (-0.5%).

Value
$4.52M
Shares
7,886
Average price
$572.69
Role
Chairperson & CEO
Holding change
-0.5%
Trade date
Nov 9, 2026
4:34 PM ET Form 4
Insider Selling

United Therapeutics Director Christopher Patusky Sells $702K of Stock

Christopher Patusky, Director, sold 1,210 shares of United Therapeutics Corp at $580.00 a share, worth $702K in total on Nov 9, 2026. Shares held after the trade: 2,140 (-36.1%).

Value
$702K
Shares
1,210
Price
$580.00
Role
Director
Holding change
-36.1%
Trade date
Nov 9, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.